-
1 Comment
VIVO Cannabis Inc is currently in a long term downtrend where the price is trading 17.8% below its 200 day moving average.
From a valuation standpoint, the stock is 99.8% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.7.
VIVO Cannabis Inc's total revenue rose by 19.0% to $7M since the same quarter in the previous year.
Its net income has increased by 48.9% to $-5M since the same quarter in the previous year.
Finally, its free cash flow grew by 62.5% to $-9M since the same quarter in the previous year.
Based on the above factors, VIVO Cannabis Inc gets an overall score of 4/5.
Industry | Drug Manufacturers - Specialty & Generic |
---|---|
Exchange | TO |
CurrencyCode | CAD |
ISIN | CA92845J1049 |
Sector | Healthcare |
Beta | 2.12 |
---|---|
Market Cap | 9M |
PE Ratio | None |
Dividend Yield | 0.0% |
Target Price | 0.7 |
VIVO Cannabis Inc. produces and sells cannabis products for the medical and adult-use markets in Canada, Germany, and Australia. It offers dried cannabis flower products, pre-rolls, and cannabis oils; and cannabis-derived products under the Canna Farms, Beacon Medical, Fireside, and Lumina brands, as well as provides cannabis-related medical information and services. The company also operates a network of medical cannabis clinics under the Harvest Medicine brand; and HMED Connect telemedicine platform, an online medical cannabis store. In addition, it engages in the ethanol extraction, product formulation, and EU-GMP related processes. The company is headquartered in Napanee, Canada.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for VIVO.TO using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025